Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 513

1.

[When to introduce hormone therapy after total prostatectomy with positive lymph nodes? Study of the factors influencing the time of introduction of hormone therapy].

Duquesne I, Champy C, Klap J, Chahwan C, Vordos D, de la Taille A, Salomon L.

Prog Urol. 2019 Dec;29(16):981-988. doi: 10.1016/j.purol.2019.09.009. Epub 2019 Nov 14. French.

PMID:
31735682
2.

Robotic versus open radical cystectomy throughout the learning phase: insights from a real-life multicenter study.

Lenfant L, Campi R, Parra J, Graffeille V, Masson-Lecomte A, Vordos D, de La Taille A, Roumiguie M, Lesourd M, Taksin L, Misraï V, Granger B, Ploussard G, Vaessen C, Verhoest G, Rouprêt M.

World J Urol. 2019 Nov 13. doi: 10.1007/s00345-019-02998-y. [Epub ahead of print]

PMID:
31720765
3.

Pulmonary Vein Varix Mimicking Prostate Cancer Metastasis on 68Ga-Prostate Specific Membrane Antigen-11 PET/CT.

Sgard B, Montravers F, Fourquet A, de la Taille A, Gauthé M.

Clin Nucl Med. 2020 Jan;45(1):e39-e40. doi: 10.1097/RLU.0000000000002803.

PMID:
31693611
4.

Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases.

Gontero P, Pisano F, Palou J, Joniau S, Albersen M, Colombo R, Briganti A, Pellucchi F, Faba OR, van Rhijn BW, van de Putte EF, Babjuk M, Fritsche HM, Mayr R, Albers P, Niegisch G, Anract J, Masson-Lecomte A, De la Taille A, Roupret M, Peyronnet B, Cai T, Witjes AJ, Bruins M, Baniel J, Mano R, Lapini A, Sessa F, Irani J, Brausi M, Stenzl A, Karnes JR, Scherr D, O'Malley P, Taylor B, Shariat SF, Black P, Abdi H, Matveev VB, Samuseva O, Parekh D, Gonzalgo M, Vetterlein MW, Aziz A, Fisch M, Catto J, Pang KH, Xylinas E, Rink M; Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology.

World J Urol. 2019 Nov 6. doi: 10.1007/s00345-019-02982-6. [Epub ahead of print]

PMID:
31691084
5.

Human CCR6+ Th17 Lymphocytes Are Highly Sensitive to Radiation-Induced Senescence and Are a Potential Target for Prevention of Radiation-Induced Toxicity.

Nguyen HQ, Belkacemi Y, Mann C, Hoffschir F, Kerbrat S, Surenaud M, Zadigue P, de La Taille A, Romeo PH, Le Gouvello S.

Int J Radiat Oncol Biol Phys. 2019 Nov 2. pii: S0360-3016(19)33969-0. doi: 10.1016/j.ijrobp.2019.10.045. [Epub ahead of print]

PMID:
31689464
6.

How many surgically-treated angiomyolipomas are related to tuberous sclerosis complex? Insights from a retrospective multicenter study.

Champy CM, Campi R, Grande P, de la Taille A, Méjean A, Granger B, Bitker MO, Roupret M.

Minerva Urol Nefrol. 2019 Oct 10. doi: 10.23736/S0393-2249.19.03522-7. [Epub ahead of print]

PMID:
31619031
7.

En bloc greenlight laser enucleation of prostate (GreenLEP): about the first hundred cases.

Panthier F, Pasquier J, Bruel S, Azancot V, De La Taille A, Gasman D.

World J Urol. 2019 Sep 5. doi: 10.1007/s00345-019-02941-1. [Epub ahead of print]

PMID:
31489477
8.

Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study.

Preisser F, van den Bergh RCN, Gandaglia G, Ost P, Surcel CI, Sooriakumaran P, Montorsi F, Graefen M, van der Poel H, de la Taille A, Briganti A, Salomon L, Ploussard G, Tilki D; EAU-YAUWP.

J Urol. 2020 Feb;203(2):338-343. doi: 10.1097/JU.0000000000000504. Epub 2019 Aug 22.

PMID:
31437119
9.

Extraperitoneal Robot-Assisted Vesicourethral Reconstruction to Manage Anastomotic Stricture Following Radical Prostatectomy.

Lavollé A, de la Taille A, Chahwan C, Champy CM, Grinholtz D, Hoznek A, Yiou R, Vordos D, Ingels A.

Urology. 2019 Nov;133:129-134. doi: 10.1016/j.urology.2019.07.027. Epub 2019 Aug 2.

PMID:
31381896
10.

Incidence of Nocturia in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement and Outcomes After Medical Treatment: Results from the Evolution European Association of Urology Research Foundation Prospective Multinational Registry.

Malde S, Patel A, Martínez-Piñeiro L, de la Taille A, Bjartell A, Tubaro A, Witjes W, Caris C.

Eur Urol Focus. 2019 Jul 22. pii: S2405-4569(19)30197-X. doi: 10.1016/j.euf.2019.07.003. [Epub ahead of print]

PMID:
31345783
11.

Erratum: CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.

Terry S, El-Sayed IY, Destouches D, Maillé P, Nicolaiew N, Ploussard G, Semprez F, Pimpie C, Beltran H, Londono-Vallejo A, Allory Y, de la Taille A, Salomon DS, Vacherot F.

Oncotarget. 2019 Jun 25;10(41):4247-4248. doi: 10.18632/oncotarget.27038. eCollection 2019 Jun 25.

12.

A preoperative nomogram to predict major complications after robot assisted partial nephrectomy (UroCCR-57 study).

Khene ZE, Peyronnet B, Bernhard JC, Kocher NJ, Vaessen C, Doumerc N, Pradere B, Seisen T, Beauval JB, Verhoest G, Roumiguié M, De la Taille A, Bruyere F, Roupret M, Mejean A, Mathieu R, Shariat S, Raman JD, Bensalah K; members of the French Committee of Urologic Oncology (CCAFU).

Urol Oncol. 2019 Sep;37(9):577.e1-577.e7. doi: 10.1016/j.urolonc.2019.05.007. Epub 2019 Jun 8.

PMID:
31186143
13.

[Evaluation of single kidney graft outcome in patients initially programmed for a dual kidney graft transplantation].

Merzeau N, Champy C, Such M, Klapp J, Chahwan C, Vordos D, Hoznek A, Matignon M, Grimbert P, de la Taille A, Salomon L.

Prog Urol. 2019 May - Jun;29(6):340-346. doi: 10.1016/j.purol.2019.04.003. French.

PMID:
31151914
14.

Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches.

Gontero P, Marra G, Alessio P, Filippini C, Oderda M, Munoz F, Linares E, Sanchez-Salas R, Challacombe B, Dasgupta P, Goonewardene S, Popert R, Cahill D, Gillatt D, Persad R, Palou J, Joniau S, Piechaud T, Morlacco A, Vidit S, Rouprêt M, De La Taille A, Albisinni S, Gandaglia G, Mottrie A, Joshi S, Fiscus G, Berger A, Aron M, Van Der Poel H, Tilki D, Lawrentschuk N, Murphy DG, Leung G, Davis J, Karnes RJ; Collaborators.

J Urol. 2019 Oct;202(4):725-731. doi: 10.1097/JU.0000000000000327. Epub 2019 Sep 6.

PMID:
31075058
15.

In Peer (Artificial Intelligence) Review We Trust.

Misrai V, de la Taille A, Rouprêt M.

Eur Urol. 2019 Jul;76(1):133-135. doi: 10.1016/j.eururo.2019.04.011. Epub 2019 Apr 26. No abstract available.

PMID:
31031047
16.

Stroma in normal and cancer wound healing.

Huet E, Jaroz C, Nguyen HQ, Belkacemi Y, de la Taille A, Stavrinides V, Whitaker H.

FEBS J. 2019 Aug;286(15):2909-2920. doi: 10.1111/febs.14842. Epub 2019 Apr 15. Review.

PMID:
30958920
17.

Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy.

Zamboni S, Foerster B, Abufaraj M, Seisen T, Roupret M, Colin P, De la Taille A, Di Bona C, Peyronnet B, Bensalah K, Herout R, Wirth MP, Novotny V, Soria F, Chlosta P, Antonelli A, Simeone C, Baumeister P, Mattei A, Montorsi F, Simone G, Gallucci M, Matsumoto K, Karakiewicz PI, Briganti A, Xylinas E, Shariat SF, Moschini M; Upper Tract Urothelial Carcinoma Collaboration Group; European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group.

BJU Int. 2019 Nov;124(5):738-745. doi: 10.1111/bju.14751. Epub 2019 Apr 7.

PMID:
30908835
18.

1,000 Retroperitoneoscopic Procedures of the Upper Urinary Tract: Analysis of Complications.

Klap J, Butow Z, Champy CM, Masson-Lecomte A, Defontaines J, De la Taille A, Salomon L.

Urol Int. 2019;102(4):406-412. doi: 10.1159/000497038. Epub 2019 Mar 6.

PMID:
30840956
19.

Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study.

Clery R, Grande P, Seisen T, Gobert A, Duquesne I, Villers A, Olivier J, Bernhard JC, Robert G, Beauval JB, Prudhomme T, Bruyère F, Lainé-Caroff P, Waltregny D, Guillonneau B, Panarello D, Ruffion A, De Bayser H, de La Taille A, Roupret M.

World J Urol. 2019 Aug;37(8):1491-1498. doi: 10.1007/s00345-019-02683-0. Epub 2019 Feb 21.

PMID:
30790014
20.

[Interest of a systematic assessment of the treatment of the lower urinary tract symptoms in the management of benign prostatic hypertrophy in general practice (1380 patients) - Study EVALURO].

Descazeaud A, Coloby P, De La Taille A, Kouri G, Mallet R, Rossi D, Rozet F, Zerbib M, Carrois F.

Prog Urol. 2019 Feb;29(2):116-126. doi: 10.1016/j.purol.2018.12.003. Epub 2019 Jan 18. French.

PMID:
30665818
21.

Simultaneous robotic total mesorectal excision and radical prostatectomy and enlarged iliac lymphadenectomy for synchronous adenocarcinomas - a video vignette.

de'Angelis N, Ingels A, de La Taille A, Brunetti F.

Colorectal Dis. 2019 Feb;21(2):249-250. doi: 10.1111/codi.14534. Epub 2018 Dec 31. No abstract available.

PMID:
30548952
22.

[Towards personalized medicine].

Robert G, de la Taille A, Descazeaud A.

Prog Urol. 2018 Nov;28(15):797-798. doi: 10.1016/j.purol.2018.09.011. Epub 2018 Oct 19. French. No abstract available.

PMID:
30348477
23.

Migration in last decade to high-risk prostate cancer after radical prostatectomy.

Patard PM, Roumiguié M, Prudhomme T, Doumerc N, Thoulouzan M, Gamé X, de la Taille A, Rischmann P, Soulié M, Salomon L, Beauval JB.

Prog Urol. 2019 Jan;29(1):29-35. doi: 10.1016/j.purol.2018.09.008. Epub 2018 Oct 15.

PMID:
30337057
24.

[Surgical treatment of BPO: Standard and innovations].

Robert G, de la Taille A, Descazeaud A.

Prog Urol. 2018 Nov;28(15):856-867. doi: 10.1016/j.purol.2018.07.287. Epub 2018 Oct 5. Review. French.

PMID:
30297185
25.

[Impact of medical and surgical treatments of LUTS on nocturia].

Robert G, De La Taille A, Descazeaud A.

Prog Urol. 2018 Nov;28(15):848-855. doi: 10.1016/j.purol.2018.08.004. Epub 2018 Sep 26. Review. French.

PMID:
30268350
26.

[Epidemiology of benign prostatic hyperplasia].

Robert G, De La Taille A, Descazeaud A.

Prog Urol. 2018 Nov;28(15):803-812. doi: 10.1016/j.purol.2018.08.005. Epub 2018 Sep 25. Review. French.

PMID:
30266373
27.

[How to prevent LUTS due to BPH development and progression].

de la Taille A, Descazeaud A, Robert G.

Prog Urol. 2018 Nov;28(15):821-829. doi: 10.1016/j.purol.2018.08.014. Epub 2018 Sep 24. Review. French.

PMID:
30262262
28.

[Consequences of prostatic obstruction on bladder function, impact of removal, and management of recurrence after surgery].

de la Taille A, Robert G, Descazeaud A.

Prog Urol. 2018 Nov;28(15):813-820. doi: 10.1016/j.purol.2018.08.013. Epub 2018 Sep 24. Review. French.

PMID:
30262261
29.

[How to evaluate BPH-related SBAUs in clinical practice and research?]

Descazeaud A, Robert G, de La Taille A.

Prog Urol. 2018 Nov;28(15):830-838. doi: 10.1016/j.purol.2018.07.277. Epub 2018 Sep 13. Review. French.

PMID:
30220536
30.

[Management of the bladder outlet obstruction associated with BPH in patients with special circumstances and/or complications].

Descazeaud A, Robert G, de La Taille A.

Prog Urol. 2018 Nov;28(15):868-874. doi: 10.1016/j.purol.2018.08.006. Epub 2018 Sep 13. Review. French.

PMID:
30220535
31.

[Is transition from pure laparoscopic to robotic-assisted radical prostatectomy associated with increase of surgical procedures for urinary incontinence and erectile dysfunction?]

Denormandie AC, de la Taille A, Salomon L, Abbou C, Yiou R.

Prog Urol. 2018 Dec;28(16):921-926. doi: 10.1016/j.purol.2018.08.008. Epub 2018 Sep 13. French.

PMID:
30219647
32.

[Sexual consequences of BPH treatments].

Descazeaud A, Robert G, de La Taille A.

Prog Urol. 2018 Nov;28(15):839-847. doi: 10.1016/j.purol.2018.07.278. Epub 2018 Sep 5. Review. French.

PMID:
30195716
33.

Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma.

Rousseau B, Guillemin A, Duvoux C, Neuzillet C, Tlemsani C, Compagnon P, Azoulay D, Salloum C, Laurent A, de la Taille A, Salomon L, Cholley I, Haioun C, Dupuis J, Wolkenstein P, Matignon MB, Grimbert P, Tournigand C.

Int J Cancer. 2019 Feb 15;144(4):886-896. doi: 10.1002/ijc.31769. Epub 2018 Nov 20.

PMID:
30155929
34.

Peri-operative and local control outcomes of robot-assisted partial nephrectomy vs percutaneous cryoablation for renal masses: comparison after matching on radiological stage and renal score.

Fraisse G, Colleter L, Peyronnet B, Khene ZE, Mandoorah Q, Soorojebally Y, Bourgi A, De La Taille A, Roupret M, De Kerviler E, Desgrandchamps F, Bensalah K, Masson-Lecomte A.

BJU Int. 2019 Apr;123(4):632-638. doi: 10.1111/bju.14530. Epub 2018 Sep 27.

PMID:
30153399
35.

Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis.

Davis NF, Jack GS, Witjes WP, Bjartell A, Caris C, Patel A, de la Taille A, Lawrentschuk N, Bolton DM, Tubaro A.

World J Urol. 2019 May;37(5):873-878. doi: 10.1007/s00345-018-2454-9. Epub 2018 Aug 25.

PMID:
30145778
36.

Ionizing radiation-induced cellular senescence promotes tissue fibrosis after radiotherapy. A review.

Nguyen HQ, To NH, Zadigue P, Kerbrat S, De La Taille A, Le Gouvello S, Belkacemi Y.

Crit Rev Oncol Hematol. 2018 Sep;129:13-26. doi: 10.1016/j.critrevonc.2018.06.012. Epub 2018 Jun 22. Review.

PMID:
30097231
37.

Laparoscopic Radical Prostatectomy in Patients with High-Risk Prostate Cancer: Feasibility and Safety. Results of a Multicentric Study.

Varca V, Benelli A, Perri D, Gozen AS, Fiedler M, de la Taille A, Casazza G, Salomon L, Rassweiler J, Gregori A, Gaboardi F.

J Endourol. 2018 Sep 12;32(9):843-851. doi: 10.1089/end.2018.0086. Epub 2018 Aug 21.

38.

The role of prostate cancer antigen 3 (PCA3) in prostate cancer detection.

Ploussard G, de la Taille A.

Expert Rev Anticancer Ther. 2018 Oct;18(10):1013-1020. doi: 10.1080/14737140.2018.1502086. Epub 2018 Jul 26. Review.

PMID:
30016891
39.

[Impact of neoadjuvant chemotherapy on the peri-operative morbidity of radical cystectomy for muscle invasive bladder cancer].

Michel C, Vordos D, Dumont C, Basset V, Meyer F, Gaudez F, Meria P, Cortesse A, Mongiat-Artus P, de la Taille A, Culine S, Desgrandchamps F, Masson-Lecomte A.

Prog Urol. 2018 Sep;28(10):495-501. doi: 10.1016/j.purol.2018.06.002. Epub 2018 Jul 8. French.

PMID:
29997033
40.

How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator.

Gandaglia G, van den Bergh RCN, Tilki D, Fossati N, Ost P, Surcel CI, Sooriakumaran P, Tsaur I, Valerio M, Kretschmer A, Zaffuto E, Salomon L, Montorsi F, Graefen M, van der Poel H, de la Taille A, Briganti A, Ploussard G; European Association of Urology Young Academic Urologists Working Party on Prostate Cancer (EAU-YAUWP).

BJU Int. 2018 Nov;122(5):823-830. doi: 10.1111/bju.14391. Epub 2018 Jun 3.

41.

Perioperative outcomes and complications of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy for bladder cancer: a real-life, multi-institutional french study.

Lenfant L, Verhoest G, Campi R, Parra J, Graffeille V, Masson-Lecomte A, Vordos D, de La Taille A, Roumiguie M, Lesourd M, Taksin L, Misraï V, Grande P, Vaessen C, Ploussard G, Granger B, Rouprêt M.

World J Urol. 2018 Nov;36(11):1711-1718. doi: 10.1007/s00345-018-2313-8. Epub 2018 May 9.

PMID:
29744571
42.

Prostatic inflammation: a potential treatment target for male LUTS due to benign prostatic obstruction.

Samarinas M, Gacci M, de la Taille A, Gravas S.

Prostate Cancer Prostatic Dis. 2018 Jun;21(2):161-167. doi: 10.1038/s41391-018-0039-8. Epub 2018 Apr 24. Review.

PMID:
29686417
43.

Impact of hospital volume and surgeon volume on robot-assisted partial nephrectomy outcomes: a multicentre study.

Peyronnet B, Tondut L, Bernhard JC, Vaessen C, Doumerc N, Sebe P, Pradere B, Guillonneau B, Khene ZE, Nouhaud FX, Brichart N, Seisen T, Alimi Q, Beauval JB, Mathieu R, Rammal A, de la Taille A, Baumert H, Droupy S, Bruyere F, Rouprêt M, Mejean A, Bensalah K; members of the French Committee of Urologic Oncology (CCAFU).

BJU Int. 2018 Jun;121(6):916-922. doi: 10.1111/bju.14175. Epub 2018 Mar 25.

44.

Prostatic injection of botulinum toxin is not inferior to optimized medical therapy in the management of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a randomized clinical trial.

Robert G, Descazeaud A, Karsenty G, Saussine C, Azzouzi AR, de la Taille A, Desgrandchamps F, Faix A, Fourmarier M, Georget A, Benard A, Barry Delongchamps N.

World J Urol. 2018 Jun;36(6):921-929. doi: 10.1007/s00345-018-2193-y. Epub 2018 Jan 30.

PMID:
29383480
45.

[Psychological impact of prostate cancer on patients receiving a 6-month androgen deprivation therapy].

de la Taille A, Mardoyan S, Lafaye A.

Prog Urol. 2018 Jan;28(1):32-38. doi: 10.1016/j.purol.2017.10.004. Epub 2017 Dec 7. French.

PMID:
29223415
46.

[Prostate cancer diagnostic by saturation randomized biopsy versus rigid targeted biopsy].

Defontaines J, Salomon L, Champy C, Cholley I, Chiaradia M, de la Taille A.

Prog Urol. 2017 Dec;27(16):1023-1030. doi: 10.1016/j.purol.2017.09.002. Epub 2017 Nov 6. French.

PMID:
29122487
47.

Reply to the Letter to the Editor by Reza Pakzad and Saeid Safiri, integration of MRI to clinical nomogram for predicting pathological stage before radical prostatectomy: bias in the prediction model.

Lebacle C, Salomon L, De La Taille A, Roudot-Thoraval F.

World J Urol. 2018 Jan;36(1):145. doi: 10.1007/s00345-017-2100-y. Epub 2017 Oct 17. No abstract available.

PMID:
29043429
48.

Extracellular vesicles released by mesenchymal-like prostate carcinoma cells modulate EMT state of recipient epithelial-like carcinoma cells through regulation of AR signaling.

El-Sayed IY, Daher A, Destouches D, Firlej V, Kostallari E, Maillé P, Huet E, Haidar-Ahmad N, Jenster G, de la Taille A, Abou Merhi R, Terry S, Vacherot F.

Cancer Lett. 2017 Dec 1;410:100-111. doi: 10.1016/j.canlet.2017.09.010. Epub 2017 Sep 19.

PMID:
28935391
49.

Trends in Radical Prostatectomy Risk Group Distribution in a European Multicenter Analysis of 28 572 Patients: Towards Tailored Treatment.

van den Bergh R, Gandaglia G, Tilki D, Borgmann H, Ost P, Surcel C, Valerio M, Sooriakumaran P, Salomon L, Briganti A, Graefen M, van der Poel H, de la Taille A, Montorsi F, Ploussard G; European Association of Urology Young Academic Urologists Working Party on Prostate Cancer (EAU-YAUWP).

Eur Urol Focus. 2019 Mar;5(2):171-178. doi: 10.1016/j.euf.2017.07.003. Epub 2017 Aug 8.

PMID:
28801241
50.

Supplemental Content

Loading ...
Support Center